Request Deal Involvement
Addimmune to go public via a SPAC merger with 10x Capital Venture Acquisition and American Gene Technologies International in a $800m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
or
Principals
target
ADDIMMUNE
bidder
10X CAPITAL VENTURE ACQUISITION III
bidder
AMERICAN GENE TECHNOLOGIES INTERNATIONAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite